Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01CYK
|
|||
| Former ID |
DIB002290
|
|||
| Drug Name |
ME1100
|
|||
| Synonyms |
Arbekacin inhalation
Click to Show/Hide
|
|||
| Indication | Bacterial pneumonia [ICD-11: CA40.0] | Phase 1 | [1] | |
| Company |
Meiji seika pharma
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial 30S ribosomal RNA (Bact 30S rRNA) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01907776) Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT01961830) Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.